Anzeige
Mehr »
Montag, 30.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
334 Leser
Artikel bewerten:
(1)

International Spinal Cord Injury Foundations Unite to Advance the Delivery of Spinal Cord Therapies, with a Focus on Combinatorial Treatment Strategies

New research alliance designed to accelerate groundbreaking therapies

LONDON and SHORT HILLS, N.J., Feb. 15, 2021 /PRNewswire/ -- The International Spinal Research Trust (ISRT) and the Christopher & Dana Reeve Foundation (Reeve Foundation) today announced a joint approach to their research strategies with a focus on accelerating the progress of therapies and their delivery to the millions of people around the world living with the life-altering effects of paralysis.

Christopher & Dana Reeve Foundation.

Sharing Knowledge, Resources and Experience
For 40 years, ISRT and the Reeve Foundation have shared a commitment to bringing therapeutics that restore function and independence to the spinal cord injury (SCI) community. This new alliance, inspired by the speed at which solutions for COVID-19 are being delivered, seeks to take a coordinated, global approach to accelerating the processes of bringing meaningful therapeutics to those living with SCI.

The new Chief Executive of ISRT, Harvey Sihota, commented, "We have seen major advances in our understanding of spinal cord biology, including improvements in diagnostics, acute treatment and rehabilitation. Building on these medical advances, we are now seeking to accelerate processes which can bring restorative treatments to those living with SCI. Given the complexity and scale of the challenge, we see a unified approach as critical to success."

A Blueprint for Speed
At the core of this alliance is a collaborative blueprint to accelerate the development and delivery of meaningful therapeutics. This will establish a framework for decision-making, planning and governance to advance the most promising therapies from the preclinical stage through clinical trials and into medical practice.

The alliance is focusing on combinatorial interventions, innovative protocols and broader stakeholder engagement for fast-tracking these interventions through the translation stage.

Jay Shepard, Chairman of the Reeve Foundation Board of Directors, remarked, "This collaborative strategy will address critical systemic issues -- including preclinical testing, optimised clinical trial design, regulatory considerations, intellectual property and the feasibility of commercialisation - that are key to bringing novel therapies to market and ensuring access for the paralysis community."

Joint Funding Supports Drive to Achieve Functional Restoration
To mark this new alliance, the two foundations have agreed to co-fund a newly created translational award, totalling £1,000,000 ($1.3 million), focused on restoring function in chronic SCI through novel circuit formation.

Dr. David Allan, Chairman of ISRT, said, "We are thrilled to be joining together to participate in this innovative effort to address one of the most complex and daunting challenges in the medical world. Our two organisations share very similar research ambitions and have grown closer in recent years. It is our privilege to get this important initiative underway and we look forward to welcoming others into a growing coalition for action."

About ISRT
Spinal Research (ISRT) is the UK's leading charity funding medical research around the world to develop effective treatments for paralysis. ISRT envisions a world without the consequences of paralysis by developing and delivering treatments to restore function to people living with spinal cord injury. Please visit http://www.spinal-research.org to find out more.

About the Christopher & Dana Reeve Foundation
The Christopher & Dana Reeve Foundation is dedicated to curing spinal cord injury by funding innovative research and improving the quality of life for individuals and families impacted by paralysis. By uniting the brightest minds in the field, we are working tirelessly to accelerate scientific discovery across the field of spinal cord research by investing in labs across the globe. Additionally, through a cooperative agreement with the Administration for Community Living, the Reeve Foundation's national Paralysis Resource Center (PRC) promotes the health, well-being, and independence of people living with paralysis, providing comprehensive information, resources, and referral services assisting over 100,000 individuals and families since its launch in 2002. The Reeve Foundation is committed to elevating our community's voices and needs to achieve greater representation and independence. We meet all 20 of the Better Business Bureau's standards for charity accountability and hold the BBB's Charity Seal. For more information, please visit our website at www.ChristopherReeve.org or call 800-225-0292.

Logo - https://mma.prnewswire.com/media/349951/christopher___dana_reeve_foundation_logo.jpg

Logo - https://mma.prnewswire.com/media/1437992/ISRT_Logo.jpg

© 2021 PR Newswire
Die USA haben fertig! 5 Aktien für den China-Boom
Die Finanzwelt ist im Umbruch! Nach Jahren der Dominanz erschüttert Donald Trumps erratische Wirtschaftspolitik das Fundament des amerikanischen Kapitalismus. Handelskriege, Rekordzölle und politische Isolation haben eine Kapitalflucht historischen Ausmaßes ausgelöst.

Milliarden strömen aus den USA – und suchen neue, lukrative Ziele. Und genau hier kommt China ins Spiel. Trotz aller Spannungen wächst die chinesische Wirtschaft dynamisch weiter, Innovation und Digitalisierung treiben die Märkte an.

Im kostenlosen Spezialreport stellen wir Ihnen 5 Aktien aus China vor, die vom US-Niedergang profitieren und das Potenzial haben, den Markt regelrecht zu überflügeln. Wer jetzt klug investiert, sichert sich den Zugang zu den neuen Wachstums-Champions von morgen.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche 5 Aktien die Konkurrenz aus den USA outperformen dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.